Truist Financial Corp grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.9% in the 4th ...

Savant Capital LLC lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 14.4% in the 4th ...

WESTBROOK, Maine - IDEXX Laboratories Inc. (NASDAQ:IDXX), a global leader in veterinary diagnostics, software, and water microbiology testing, announced the immediate resignation of Dr. Asha Collins ...

Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2024 investor letter. A copy of ...

WESTBROOK, Maine, February 13, 2025--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, ...

As of Thursday morning, IDEXX Laboratories shares are down by 0.49%, with a current price of $455.12. This implies that Erickson's 1,544 shares have a value of $597,944.

The Wednesday morning market activity shows IDEXX Laboratories shares down by 0.74%, trading at $460.32. This implies a total value of $4,280,728 for Fennell's 11,242 shares.

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

George Fennell, Executive Vice President at IDEXX Laboratories Inc. (NASDAQ:IDXX), a company with a market capitalization of $37.95 billion and currently trading near $463.74, recently sold 9,986 ...

IDEXX Laboratories (NASDAQ:IDXX – Free Report) had its price objective upped by Piper Sandler from $435.00 to $510.00 in a research report report published on Monday morning,Benzinga reports. Piper ...